Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chemical Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd/Cu catalyzed route offers high yields and simplified purification for complex pharmaceutical intermediates, ensuring supply chain stability.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable supply and cost-effective API intermediate manufacturing.
Patent CN115353511A details a novel multi-component Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost-effective routes for API intermediates.
Patent CN111423381B details a mild Pd-catalyzed route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Patent CN114409600A reveals a high-yield Grignard route for Enilconazole, offering superior purity and scalability for global fungicide manufacturers.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones using nitro compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN114773242A details a novel nickel-catalyzed route for alpha,beta-unsaturated thioesters, offering cost-effective alternatives to precious metal methods for pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN113234015B discloses a high-yield one-pot synthesis of 3-acyl dihydroquinolines. This route offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102180794B details a mild, aqueous synthesis of nitrobenzenes from arylboronic acids, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113045489A details a novel Pd-catalyzed route to quinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115353511A discloses a safe, multi-component palladium-catalyzed method for synthesizing carbonyl-bridged biheterocycles using in-situ carbon monoxide generation.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Efficient Ag2CO3 catalyzed synthesis of polysubstituted pyrroles from alkynes and isocyanides. Cost-effective pharma intermediate manufacturing with high purity.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115353511A reveals a safe Pd-catalyzed carbonylation method for synthesizing indolinone-imidazole hybrids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel reductive aminocarbonylation route using nitroarenes offers high yields and simplified purification for complex pharmaceutical intermediates.
Patent CN109651421B details a cost-effective Ru-catalyzed C-H silylation. Offers high yields up to 85% for pharmaceutical intermediates, ensuring reliable supply chain stability.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.